These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 22994731)
1. Presence of anemia and poor prognostic factors in patients with endometrial carcinoma. Wilairat W; Benjapibal M Asian Pac J Cancer Prev; 2012; 13(7):3187-90. PubMed ID: 22994731 [TBL] [Abstract][Full Text] [Related]
2. Preoperative thrombocytosis and poor prognostic factors in endometrial cancer. Heng S; Benjapibal M Asian Pac J Cancer Prev; 2014; 15(23):10231-6. PubMed ID: 25556452 [TBL] [Abstract][Full Text] [Related]
3. Preoperative hemoglobin and platelet count and poor prognostic factors in patients with endometrial carcinoma. Metindir J; Bilir Dilek G J Cancer Res Clin Oncol; 2009 Jan; 135(1):125-9. PubMed ID: 18542999 [TBL] [Abstract][Full Text] [Related]
4. Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Tamussino KF; Gücer F; Reich O; Moser F; Petru E; Scholz HS Int J Gynecol Cancer; 2001; 11(3):236-40. PubMed ID: 11437932 [TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study. Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243 [TBL] [Abstract][Full Text] [Related]
6. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer. Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481 [TBL] [Abstract][Full Text] [Related]
7. Preoperative Anemia as a Prognostic Factor in Endometrioid-Type Endometrial Carcinoma. Abu-Zaid A; Alsabban M; Abuzaid M; Alomar O; Salem H; Al-Badawi IA J Obstet Gynaecol Can; 2018 Nov; 40(11):1393-1400. PubMed ID: 30473117 [TBL] [Abstract][Full Text] [Related]
8. [Clinical implications of positive peritoneal cytology in endometrial cancer]. Ren YL; Wang HY; Shan BE; Ping B; Shi DR Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518 [TBL] [Abstract][Full Text] [Related]
9. Long-term survival in patients with para-aortic lymph node metastasis with systematic retroperitoneal lymphadenectomy followed by adjuvant chemotherapy in endometrial carcinoma. Hiura M; Nogawa T; Matsumoto T; Yokoyama T; Shiroyama Y; Wroblewski J Int J Gynecol Cancer; 2010 Aug; 20(6):1000-5. PubMed ID: 20683408 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of DNA topoisomerase II-alpha (Ki-S1) immunoexpression in endometrial carcinoma. Bildrici K; Tel N; Ozalp SS; Yalcin OT; Yilmaz V Eur J Gynaecol Oncol; 2002; 23(6):540-4. PubMed ID: 12556100 [TBL] [Abstract][Full Text] [Related]
11. Preoperative anemia predicts poor prognosis in patients with endometrial cancer: A systematic review and meta-analysis. Abu-Zaid A; Alomar O; Abuzaid M; Baradwan S; Salem H; Al-Badawi IA Eur J Obstet Gynecol Reprod Biol; 2021 Mar; 258():382-390. PubMed ID: 33529973 [TBL] [Abstract][Full Text] [Related]
12. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer. Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407 [TBL] [Abstract][Full Text] [Related]
13. Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Chung HH; Kim JW; Park NH; Song YS; Kang SB; Lee HP Acta Obstet Gynecol Scand; 2006; 85(12):1501-5. PubMed ID: 17260229 [TBL] [Abstract][Full Text] [Related]
14. [Multivariate analysis of prognostic factors in endometrial carcinoma]. Li B; Wu LY; Li SM; Zhang WH; Zhang R; Ma SK Ai Zheng; 2004 Sep; 23(9):1085-8. PubMed ID: 15363208 [TBL] [Abstract][Full Text] [Related]
15. Parametrial spread is a prognostic factor in endometrial carcinoma. Sato R; Jobo T; Kuramoto H Eur J Gynaecol Oncol; 2003; 24(3-4):241-5. PubMed ID: 12807232 [TBL] [Abstract][Full Text] [Related]
16. Treatment results of endometrial carcinoma with positive peritoneal washing, adnexal involvement and serosal involvement. Wong FC; Pang CP; Tang SK; Tung SY; Leung TW; Sze WK; Cheung KB Clin Oncol (R Coll Radiol); 2004 Aug; 16(5):350-5. PubMed ID: 15341439 [TBL] [Abstract][Full Text] [Related]
17. Value of pre-operative serum CA125 level for prediction of prognosis in patients with endometrial cancer. Chen YL; Huang CY; Chien TY; Huang SH; Wu CJ; Ho CM Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):397-402. PubMed ID: 21806586 [TBL] [Abstract][Full Text] [Related]
18. The relationship between mutant p53 gene, DNA contents and conventional clinicopathological prognostic variables in cases with endometrial carcinoma. Osmanağaoğlu MA; Kadioğlu S; Osmanağaoğlu S; Bozkaya H; Reis A; Tekelioğlu Y Eur J Gynaecol Oncol; 2005; 26(1):64-70. PubMed ID: 15755004 [TBL] [Abstract][Full Text] [Related]
19. The Significance of Pretreatment Thrombocytosis and Its Association With Neutrophilia in Patients With Surgically Treated Endometrial Cancer. Takahashi R; Mabuchi S; Kuroda H; Kozasa K; Yokoi E; Matsumoto Y; Kimura T Int J Gynecol Cancer; 2017 Sep; 27(7):1399-1407. PubMed ID: 28604454 [TBL] [Abstract][Full Text] [Related]
20. Adnexal Involvement in Endometrial Cancer: Prognostic Factors and Implications for Ovarian Preservation. Baiocchi G; Clemente AG; Mantoan H; da Costa WL; Bovolim G; Guimaraes APG; da Costa AABA; De Brot L; Faloppa CC Ann Surg Oncol; 2020 Aug; 27(8):2822-2826. PubMed ID: 32080810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]